{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:15:19Z","timestamp":1761675319920},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2000,3]]},"DOI":"10.1067\/mob.2000.104768","type":"journal-article","created":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T16:38:55Z","timestamp":1146501535000},"page":"568-574","source":"Crossref","is-referenced-by-count":41,"title":["Uterine effects of raloxifene in comparison with continuous-combined hormone replacement therapy in postmenopausal women"],"prefix":"10.1067","volume":"182","author":[{"given":"Pierre","family":"Fug\u00e8re","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wim H.","family":"Scheele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aarti","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas R.","family":"Strack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Glant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine","family":"Jolly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1067\/mob.2000.104768_bib1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.1995.03520270033028","article-title":"Effects of estrogen or estrogen\/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen\/Progestin Interventions (PEPI) Trial","volume":"273","author":"PEPI Trial Writing Group","year":"1995","journal-title":"JAMA"},{"key":"10.1067\/mob.2000.104768_bib2","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/jama.1996.03530290040035","article-title":"Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen\/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial","volume":"275","author":"PEPI Trial Writing Group","year":"1996","journal-title":"JAMA"},{"key":"10.1067\/mob.2000.104768_bib3","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0002-9378(94)70129-6","article-title":"Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. The Menopause Study Group","volume":"170","author":"Woodruff","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1067\/mob.2000.104768_bib4","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0140-6736(96)07365-5","article-title":"Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women","volume":"349","author":"Beresford","year":"1997","journal-title":"Lancet"},{"key":"10.1067\/mob.2000.104768_bib5","first-page":"686","article-title":"Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. The Menopause Study Group","volume":"83","author":"Archer","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1067\/mob.2000.104768_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/bmj.315.7099.37","article-title":"Management of abnormal bleeding in women receiving hormone replacement therapy","volume":"315","author":"Spencer","year":"1997","journal-title":"BMJ"},{"key":"10.1067\/mob.2000.104768_bib7","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/0002-9378(95)90247-3","article-title":"Benefits and risks of estrogen replacement therapy","volume":"173","author":"Lobo","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1067\/mob.2000.104768_bib8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00001703-199806000-00002","article-title":"Selective oestrogen receptor modulators: A new paradigm for HRT","volume":"10","author":"Baynes","year":"1998","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1067\/mob.2000.104768_bib9","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(97)11423-4","article-title":"Tamoxifen for early breast cancer: an overview of the randomised trials","volume":"351","author":"Early Breast Cancer Trialists\u2019 Collaborative Group","year":"1998","journal-title":"Lancet"},{"key":"10.1067\/mob.2000.104768_bib10","series-title":"Nolvadex (tamoxifen citrate) [package insert]","year":"1998"},{"key":"10.1067\/mob.2000.104768_bib11","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study","volume":"90","author":"Fisher","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1067\/mob.2000.104768_bib12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/978-1-4615-6189-7_11","article-title":"Tamoxifen and the endometrium","volume":"94","author":"Barakat","year":"1998","journal-title":"Cancer Treat Res"},{"key":"10.1067\/mob.2000.104768_bib13","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/S0140-6736(94)92466-X","article-title":"Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial","volume":"343","author":"Kedar","year":"1994","journal-title":"Lancet"},{"key":"10.1067\/mob.2000.104768_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0378-5122(96)01043-2","article-title":"Transvaginal ultrasonography and endometrial changes in postmenopausal breast cancer patients receiving tamoxifen","volume":"25","author":"Dijkhuizen","year":"1996","journal-title":"Maturitas"},{"key":"10.1067\/mob.2000.104768_bib15","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1056\/NEJM199712043372301","article-title":"Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women","volume":"337","author":"Delmas","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1067\/mob.2000.104768_bib16","first-page":"S174","article-title":"The effect of 2 and 3 years of raloxifene on vertebral and non-vertebral fractures in postmenopausal women with osteoporosis","volume":"23","author":"Ensrud","year":"1998","journal-title":"Bone"},{"key":"10.1067\/mob.2000.104768_bib17","series-title":"Two-year findings from the Multiple Outcomes of Raloxifene Evaluation (MORE) Trial","first-page":"2a","article-title":"Raloxifene reduces the risk of breast cancer and may decrease the risk of endometrial cancer in postmenopausal women","author":"Cummings","year":"1998"},{"key":"10.1067\/mob.2000.104768_bib18","first-page":"411","article-title":"Endometrial hyperplasia and related cellular changes","author":"Kurman","year":"1994"},{"key":"10.1067\/mob.2000.104768_bib19","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/S0002-9378(97)70091-7","article-title":"Effects of raloxifene hydrochloride on the endometrium of postmenopausal women","volume":"177","author":"Boss","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1067\/mob.2000.104768_bib20","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/jbmr.5650110615","article-title":"A controlled trial of raloxifene (LY139481) HCl: impact on bone turnover and serum lipid profile in healthy postmenopausal women","volume":"11","author":"Draper","year":"1996","journal-title":"J Bone Miner Res"},{"key":"10.1067\/mob.2000.104768_bib21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(89)91141-0","article-title":"Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers","volume":"1","author":"Fornander","year":"1989","journal-title":"Lancet"},{"key":"10.1067\/mob.2000.104768_bib22","first-page":"660","article-title":"Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen","volume":"81","author":"Lahti","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1067\/mob.2000.104768_bib23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1006\/gyno.1995.0019","article-title":"Comparison between the effects of tamoxifen and toremifene on the uterus in postmenopausal breast cancer patients","volume":"59","author":"Tomas","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1067\/mob.2000.104768_bib24","first-page":"95","article-title":"A 12-month comparative study of raloxifene, estrogen, and placebo on the postmenopausal endometrium","volume":"95","author":"Goldstein","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1067\/mob.2000.104768_bib25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0889-8545(21)00584-2","article-title":"The effects of estrogens and progestogens on the endometrium. Modern approach to treatment","volume":"14","author":"Whitehead","year":"1987","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1067\/mob.2000.104768_bib26","first-page":"558","article-title":"Adverse events reported by postmenopausal women in controlled trials with raloxifene","volume":"93","author":"Davies","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1067\/mob.2000.104768_bib27","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/jama.279.18.1445","article-title":"Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women","volume":"279","author":"Walsh","year":"1998","journal-title":"JAMA"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937800800162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937800800162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T13:03:04Z","timestamp":1627304584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937800800162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["S0002937800800162"],"URL":"https:\/\/doi.org\/10.1067\/mob.2000.104768","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2000,3]]}}}